Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6391-6401
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6391
Figure 1
Figure 1 Annual endoscopic retrograde cholangiopancreatography volume progressively increased from 2008 to 2018. ERCP: Endoscopic retrograde cholangiopancreatography.
Figure 2
Figure 2 Mean age of patients progressively increased significantly from 2008 to 2018.
Figure 3
Figure 3 Proportion of endoscopic retrograde cholangiopancreatography performed for management of malignant biliary strictures increased from 2008 to 2018, but this did not reach statistical significance.
Figure 4
Figure 4 Proportion of endoscopic retrograde cholangiopancreatography performed with the duodenoscope in a non-standard position increased significantly from 2008 to 2018.
Figure 5
Figure 5 Progressive increase in the frequency of ampullary distortion/tumor infiltration, duodenal distortion/stenosis and peri-ampullary diverticula was noted in over the study period. ERCP: Endoscopic retrograde cholangiopancreatography.
Figure 6
Figure 6 Utilization of more than one advanced cannulation technique for a given endoscopic retrograde cholangiopancreatography increased significantly over the study period.
Figure 7
Figure 7 Over the study period, there was an increasing proportion of procedures with oropharyngeal, esophageal, gastric and duodenal barriers to duodenoscope advancement and cannulation. A: Qropharyngeal barriers to duodenoscope advancement and cannulation; B: Esophageal barriers to duodenoscope advancement and cannulation; C: Gastric barriers to duodenoscope advancement and cannulation; D: Duodenal barriers to duodenoscope advancement and cannulation.